Literature DB >> 24222196

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

Irina Kuznetsova1, Anna-Polina Shurygina2, Brigitte Wolf1, Markus Wolschek3,1, Florian Enzmann1, Abylay Sansyzbay4, Berik Khairullin4, Nurlan Sandybayev4, Marina Stukova2, Oleg Kiselev2, Andrej Egorov2, Michael Bergmann5,1.   

Abstract

The development of influenza virus vectors with long insertions of foreign sequences remains difficult due to the small size and instable nature of the virus. Here, we used the influenza virus inherent property of self-optimization to generate a vector stably expressing long transgenes from the NS1 protein ORF. This was achieved by continuous selection of bright fluorescent plaques of a GFP-expressing vector during multiple passages in mouse B16f1 cells. The newly generated vector acquired stability in IFN-competent cell lines and in vivo in murine lungs. Although improved vector fitness was associated with the appearance of four coding mutations in the polymerase (PB2), haemagglutinin and non-structural (NS) segments, the stability of the transgene expression was dependent primarily on the single mutation Q20R in the nuclear export protein (NEP). Importantly, a longer insert, such as a cassette of 1299 nt encoding two Mycobacterium tuberculosis Esat6 and Ag85A proteins, could substitute for the GFP transgene. Thus, the inherent property of the influenza virus to adapt can also be used to adjust a vector backbone to give stable expression of long transgenes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24222196     DOI: 10.1099/vir.0.056036-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

Review 1.  From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.

Authors:  Julijan Kabiljo; Johannes Laengle; Michael Bergmann
Journal:  Cell Death Discov       Date:  2020-06-11

2.  Generation of a variety of stable Influenza A reporter viruses by genetic engineering of the NS gene segment.

Authors:  Peter Reuther; Kristina Göpfert; Alexandra H Dudek; Monika Heiner; Susanne Herold; Martin Schwemmle
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

3.  Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.

Authors:  Irina Kuznetsova; Tobias Arnold; Thomas Aschacher; Cornelia Schwager; Balazs Hegedus; Tamas Garay; Marina Stukova; Maria Pisareva; Stephan Pleschka; Michael Bergmann; Andrej Egorov
Journal:  Mol Ther Oncolytics       Date:  2017-09-08       Impact factor: 7.200

4.  Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription/Replication Efficiency of the Modified Segment.

Authors:  Yuri Furusawa; Shinya Yamada; Tiago Jose da Silva Lopes; Jayeeta Dutta; Zenab Khan; Divya Kriti; Harm van Bakel; Yoshihiro Kawaoka
Journal:  mBio       Date:  2019-10-01       Impact factor: 7.867

5.  Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs.

Authors:  Mariia Sergeeva; Ekaterina Romanovskaya-Romanko; Natalia Zabolotnyh; Anastasia Pulkina; Kirill Vasilyev; Anna Polina Shurigina; Janna Buzitskaya; Yana Zabrodskaya; Artem Fadeev; Andrey Vasin; Tatiana I Vinogradova; Marina A Stukova
Journal:  Vaccines (Basel)       Date:  2021-04-16

Review 6.  From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.

Authors:  Julijan Kabiljo; Johannes Laengle; Michael Bergmann
Journal:  Cell Death Discov       Date:  2020-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.